The global retail colocation market is expected to earn around US$ 27,554.0 million by 2032, up from US$ 8,645.0 million in 2022, with a CAGR of 12.3% over the forecast period. Because of the growing acceptance of cloud and IoT advancements, retail colocation has grown in popularity in the last few years. One of the key factors …
Monthly Archives: May 2023
Joint Reconstruction Devices Market is likely to propel to US$ 41.5 Billion by 2032, at a 4.8% CAGR from 2022 to 2032
The global joint reconstruction devices market is worth US$ 26 Bn as of now and is expected to reach US$ 41.5 Bn by the year 2032 at a CAGR of 4.8% between 2022 and 2032. Joint reconstruction comes across as a remarkable part of global orthopedic devices vertical. The conditions adversely affecting joints are inclusive of all …
Digital Patient Monitoring Systems Market expanding at a CAGR of 17.2% through the forecast period of 2022 to 2032 | FMI Study
Future Market Insights, a market research and competitive intelligence provider, analyses that market demand for Digital Patient Monitoring Systems is expected to rise rapidly on the back of increasing demand for remote patient monitoring activities and increasing penetration in developing countries. According to the study, the global Digital Patient Monitoring Systems market was valued at US$ 73.7 …
Neuroendoscopy Devices Market is expected to expand from US$ 165.0 Million in 2022 to US$ 343.2 Million in 2032
The neuroendoscopy devices market is expected to escalate at a CAGR of 7.6% from USD 165.0 Million in 2022 to USD 343.2 Million through 2032. Globally increasing brain tumour incidences and technological advancements in neuroendoscopic devices will lead to growth opportunities for the neuroendoscopic devices market. In 2021, after delayed elective procedures are completed, and vaccines are available, …
Arteriovenous Fistula Treatment Market is predicated to amass revenue of about US$ 1,381.1 Million by 2032
[340 Pages Report] The global arteriovenous fistula treatment market is projected to amass revenue of about US$ 1,381.1 Mn by 2032, up from US$ 731.6 Mn in 2022, advancing at a CAGR of 5.9% during the forecast period. Arteriovenous Fistula Treatment Market: Region-wise OutlookGeographically, Arteriovenous Fistula Treatment Market is segmented into North America, Latin America, Western Europe, Eastern Europe, …
Compression Garments and Stockings Market is expected to reach US$ 3.9 Billion by the end of 2029
Expanding at a CAGR of 4.9%, the global Compression Garments and Stockings Market is expected to increase from a valuation of US$ 2.8 Bn in 2022 to US$ 3.9 Bn by 2029. Increasing demand for compression garments to avoid sports injuries is prominently driving sales of compression garments and stockings in the global market. Surpassing revenues worth …
Brain Imaging And Neuroimaging Market is likely to grow at a moderate CAGR of 5.1% totaling around US$ 21,569.7 Million by 2032
The global Brain Imaging And Neuroimaging Market is expected to be worth US$ 13,166.5 Million by 2022, with a 5.1% CAGR between 2022 and 2032, totaling around US$ 21,569.7 Million by 2032. Over the last few years, the healthcare industry has been witnessing technological advances in medical devices which offer robust services to cater to patients who …
Advanced Infusion Systems Market is likely to a valuation of US$ 15,820.03 million by 2032 at a CAGR of 6.4%
The global Advanced Infusion Systems Market is likely to be valued at US$ 8,470.25 million in 2022 and is predicted to secure a slow-paced CAGR of 6.4% during the forecast period. The global advanced infusion systems market is likely to be valued at US$ 8,470.25 million in 2022 and is predicted to secure a slow-paced CAGR of 6.4% during the …
Veterinary Auto-immune Disease Therapeutics Market | Pfizer Inc., Vet-Stem Inc., Ambrx Inc., Taconic Biosciences, Inc. | By 2032
Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Veterinary Auto-immune Disease Therapeutics Market. The study features insights on the current growth dynamics and the major revenue reforms prevailing in the market as of 2020 along with the key takeaways over the forecast period. The market for …
Antisense Oligonucleotides Market | Bio-Path Holdings, Inc., Gene Signal International SA, GlaxoSmithKline plc, Geron Corporation | By 2032
The global Antisense Oligonucleotides Market is expected to generate US$ 5,659.2 million in revenue by 2032, up from US$ 1,921.6 million in 2022, with a CAGR of 10.3% over the forecast period. Antisense Oligonucleotides market players – Ionis Pharmaceuticals, Inc., Sarepta Therapeutics, Biogen, Alnylam Pharmaceuticals, Inc., Antisense Therapeutics Limited among others represent the global Antisense Oligonucleotides market. The market study depicts an extensive …